These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11091024)

  • 1. Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats.
    Parkes H; Sinclair JD
    Alcohol; 2000 Jul; 21(3):215-21. PubMed ID: 11091024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol drinking and naltrexone on subsequent drinking in rats.
    Davidson D; Amit Z
    Alcohol; 1997; 14(6):581-4. PubMed ID: 9401674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.
    Rasmussen DD; Kincaid CL; Froehlich JC
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1832-41. PubMed ID: 26260061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.
    Froehlich JC; Fischer SM; Nicholson ER; Dilley JE; Filosa NJ; Smith TN; Rademacher LC
    Alcohol Clin Exp Res; 2017 Mar; 41(3):644-652. PubMed ID: 28055135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
    Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P
    Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol consumption is enhanced after naltrexone treatment.
    Juárez J; Eliana Bde T
    Alcohol Clin Exp Res; 2007 Feb; 31(2):260-4. PubMed ID: 17250617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection.
    Williams KL; Broadbridge CL
    Alcohol; 2009 Mar; 43(2):119-26. PubMed ID: 19251113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.
    Froehlich JC; Hausauer BJ; Rasmussen DD
    Alcohol Clin Exp Res; 2013 Oct; 37(10):1763-70. PubMed ID: 23875623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats.
    Perfumi M; Mattioli L; Cucculelli M; Massi M
    J Psychopharmacol; 2005 Sep; 19(5):448-54. PubMed ID: 16166181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
    Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.
    Zhou Y; Kreek MJ
    Brain Res; 2019 Dec; 1724():146410. PubMed ID: 31469985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone blocks acquisition of voluntary ethanol intake in rats.
    Davidson D; Amit Z
    Alcohol Clin Exp Res; 1997 Jun; 21(4):677-83. PubMed ID: 9194924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.
    Krishnan-Sarin S; O'Malley SS; Franco N; Cavallo DA; Tetrault JM; Shi J; Gueorguieva R; Pittman B; Krystal JH
    Neuropsychopharmacology; 2020 Jan; 45(2):319-326. PubMed ID: 31590179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic naltrexone and propensity to take alcoholic beverage.
    Reid LD; Gardell LR; Chattopadhyay S; Hubbell CL
    Alcohol Clin Exp Res; 1996 Nov; 20(8):1329-34. PubMed ID: 8947306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone.
    Coonfield DL; Kiefer SW; Ferraro FM; Sinclair JD
    Behav Neurosci; 2004 Oct; 118(5):1089-96. PubMed ID: 15506891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.
    Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER
    Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericum perforatum CO2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats.
    Perfumi M; Santoni M; Cippitelli A; Ciccocioppo R; Froldi R; Massi M
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1554-62. PubMed ID: 14574225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference.
    Nestby P; Schoffelmeer AN; Homberg JR; Wardeh G; De Vries TJ; Mulder AH; Vanderschuren LJ
    Psychopharmacology (Berl); 1999 Mar; 142(3):309-17. PubMed ID: 10208324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.
    Gardell LR; Whalen CA; Chattophadyay S; Cavallaro CA; Hubbell CL; Reid LD
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1435-9. PubMed ID: 9394115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.